Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Craig Jones

CNBC's Final Trades: CVS Health, AbbVie And This Travel Stock

On CNBC’s “Halftime Report Final Trades,” Joseph Terranova of Virtus Investment Partners recommended to sell CVS Health Corp (NYSE:CVS). Terranova said he had bought the stock on January 20 at $101 and “it’s gone nowhere.”

Bryn Talkington of Requisite Capital Management named AbbVie Inc (NYSE:ABBV) for those looking for stocks outside energy and commodity. “It’s done great this year. It’s got a really nice dividend of over 3.4%. I think it gives good diversification with strong technicals and fundamentals,” she added.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.